Climacteric
Conditions
Keywords
climacteric, complementary therapy, hormonal replacement therapy
Brief summary
The alternative and complementary therapies are being gradually included in the Brazilian Health Unique System (SUS), as it is foreseen in the National Politics of Integrative and Complementary Practices in Brazil . However, though this thematic is also included in the National Agenda of Research Priorities concerning Health, published studies concerning this matter are quite scarce. The World Health Organization (WHO) indicated that it is a big challenge to effect the following studies: cost-effectiveness, as well as safety, efficiency and the quality of such practices. WHO also pointed out the clinical situations where they could be applied and that is why this investigation we are undertaken is fully justified. Annoying signs and symptoms which come along with the climacteric period, especially anxiety, insomnia and hot flushes, change women´s life quality and their affective, social and business relationships as well. Consequently, this can generate sadness, depression and isolation. Many women cannot undergo hormonal replacement, for several reasons: or they have some illnesses which reject hormones, or due to hypersensitiveness reactions or even economical difficulties. Also, the cost-effectiveness ratio between conventional therapy of hormonal replacement and complementary therapies which compose this study are not known yet . The complementary therapies proposed in this study concern non-invasive methods, of low cost, which justify being researched in order to verify the potential of those annoying signs alleviation.
Interventions
OTHERflower therapy
Each woman will perform 12 sessions of 20 to 30 minutes, depending on the treatment group, with weekly intervals performed in one of the consultation rooms.
OTHERtherapeutic touch
Each woman will perform 12 sessions of 20 to 30 minutes, depending on the treatment group, with weekly intervals performed in one of the consultation rooms.
OTHERauricular therapy
Each woman will perform 12 sessions of 20 to 30 minutes, depending on the treatment group, with weekly intervals performed in one of the consultation rooms.
DRUGHormones
Estradiol 1 mg and a drospirenone 2mg/day (3 months)
Sponsors
University of Sao Paulo
Sociedade Hospital Samaritano
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
45 Years to 55 Years
Healthy volunteers
Yes
Inclusion criteria
* Female * Recruited and registered in local of the study * They should present the signs and symptoms checked - insomnia, anxiety and hot flushes, they felt at the beginning of the climacteric * They should not be under hormonal replacement or even should have stopped their use more than 90 days
Exclusion criteria
* women who undergo a hysterectomy surgery * women using hormonal therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| annoying signs and climacteric symptoms | pre and post intervention |
Countries
Brazil
Outcome results
None listed